YearPaper
2007 Barlow DP, Bartolomei MS. Genomic imprinting in mammals. Chapter 19 in EPIGENETICS Edited by D. Allis, T. Jenuwein D. Reinberg. CSH Press 2007. ISBN 978-087969724–2. Book Chapter.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24492710
2007 Binder CJ, Hartvigsen K, Witztum JL. Promise of immune modulation to inhibit atherogenesis. J Am Coll Cardiol. 2007, 50(6):547–50. 
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17678739
2007 Bro S, Binder CJ, Witztum JL, Olgaard K, Nielsen LB. Inhibition of the Renin-Angiotensin System Abolishes the Proatherogenic Effect of Uremia in Apolipoprotein E-Deficient Mice. Arterioscl Thromb Vasc Biol. 2007, 27(5):1080–6. 
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17347482
2007 Colinge J, Bennett KL. Introduction to computational proteomics. PLoS Comput Biol 2007, 3:e114. 
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1933459/
2007 Colinge J. Peptide fragment intensity statistical modelling. Anal Chem 2007, 79, 7286–7290.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17713966
2007 Dessing M, Knapp S, Florquin S, de Vos AF, van der Poll T. CD14 facilitates invasive respiratory tract infections by Streptococcus pneumoniae. Am J Respir Crit Care Med. 2007, 175:604–611. 
Abstract: http://www.atsjournals.org/doi/full/10.1164/rccm.200606-824OC#.UrGhL-JHLcY
2007 Gattringer R, Lagler H, Gattringer KB, Knapp S, Burgmann H, et al. Anakinra in two adolescent female patients suffering from colchicineresistant familial Mediterranean fever: effective but risky. Eur J Clin Invest. 2007, 37:912–914.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17973784
2007 Hantschel O, Rix U, Schmidt U, Burckstummer T, Kneidinger M, Schutze G, Colinge J, Bennett KL, Ellmeier W, Valent P, Superti-Furga G. The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib. Proc Natl Acad Sci USA. 2007, 104:13283–13288.
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1940229/
2007 Hartvigsen K, Binder CJ, Hansen LF, Rafia A, Juliano J, et al. A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome. Arterioscl Thromb Vasc Biol. 2007, 27(4):878–85.
Abstract: http://atvb.ahajournals.org/content/27/4/878.long
2007 Kakkad R, Sloane MA, Huang R, Pauler FM, Warczok KE, Melikant B, Radolf M, Martens JHA, Schotta G, Jenuwein T, Barlow DP. Active and Repressive Chromatin Is Interspersed without Spreading in an Imprinted Gene Cluster in the Mammalian Genome. Mol Cell. 2007, 27(3):353–66. 
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847180/
2007 Knapp S, Matt U, Leitinger N, van der Poll T. Oxidized phospholipids inhibit phagocytosis and impair outcome in gram-negative sepsis in vivo. J Immunol. 2007, 178:993–1001.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17202362
2007 Knapp S. Innate recognition of bacteria. Expert Rev Clin Immunol. 2007, 3:443–445 (Editorial).
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20477147
2007 Kocher T, Superti-Furga G. Mass spectrometry-based functional proteomics: from molecular machines to protein networks. Nat Methods. 2007, 4(10):807–15.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17901870
2007 Orchard S, Salwinski L, Kerrien S, Montecchi- Palazzi L, Oesterheld M, Stumpflen V, Ceol A, Chatr-aryamontri A, Armstrong J, Woollard P, Salama JJ, Moore S, Wojcik J, Bader GD, Vidal M, Cusick ME, Gerstein M, Gavin AC, Superti-Furga G, et al. The minimum information required for reporting a molecular interaction experiment (MIMIx). Nat Biotechnol. 2007, 25(8):894–8.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17687370
2007 Pauler FM, Koerner MV, Barlow DP. Silencing by imprinted noncoding RNAs: is transcription the answer? Trends Genet. 2007, 23(6):284–92.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17445943
2007 Pitzer E, Masselot A, Colinge J. Assessing peptide de novo sequencing algorithms performance on large and diverse data sets. Proteomics 2007, 7:3051–3054.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17683051
2007 Rix U, Hantschel O, Dürnberger G, Remsing Rix LL, Planyavsky M, Fernbach NV, Kaupe I, Bennett KL, Valent P, Colinge J, Köcher T, Superti-Furga G. Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib reveal novel kinase and non-kinase targets. Blood. 2007, 110:4055–4063.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17720881
2007 Schuster C, Fernbach N, Rix U, Superti-Furga G, Holy M, Freissmuth M, Sitte HH, Sexl V. Selective serotonin reuptake inhibitors – A new modality for the treatment of lymphoma/leukaemia? Biochem Pharmacol. 2007, 74(9):1424–35.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17709099